Discovery Holds Promise for 'Bubble Boy’ Patients
December 07, 2013
An international study
led by Dana-Farber Cancer Institute and Boston Children's Hospital has shown
that a new type of gene therapy may help boys with a fatal immune disorder
commonly known as “bubble boy” disease, the Boston Business Journal reports. A
new delivery method for the gene therapy is designed to prevent patients from
developing leukemia, a side effect that emerged during a similar trial 10 years
ago, and doused hopes for the treatment.
Read the full story. Read the news release.